Phase II Trial of Extended-Dosing Temozolomide in Patients With Melanoma
Clinical trial NCT00591370 · COMPLETED
Trial details
- NCT number
- NCT00591370
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2008-06-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.